Fumihiko Ishikawa

11PUBLICATIONS
111CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical microbiology not elsewhere classifiedGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2026
Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosis.

|Jan 26, 2026
CXCR4 induces memory formation over exhaustion in CAR-T cells to achieve durable leukemia targeting.

Ari Itoh-Nakadai, Minggao Liang, Michiho Shindo

|May 19, 2025
TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.

Rosa A van Amerongen, Sander Tuit, Dennis F G Remst

|Dec 13, 2023
Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.

Akira Nishimura, Kazuaki Yokoyama, Takuya Naruto

|Aug 30, 2022
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia.

Tomoya Isobe, Masatoshi Takagi, Aiko Sato-Otsubo

|Feb 05, 2022
Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia.

Mari Hashimoto, Yoriko Saito, Ryo Nakagawa

Pageof 2

Frequent Collaborators

3 joint publications

Osamu Ohara

2 joint publications

Akira Nishimura

2 joint publications

Tomohiro Morio

2 joint publications

Masatoshi Takagi